Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Yew Bio-Pharm Group, Inc. YEWB

Set alert

Price alert · YEWB

All alert types
0.00 0.00 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
11.84K
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
—
High
—

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for YEWB has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.26 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 3.7×
FY 2011: 9.0×FY 2012: 18.0×FY 2013: 13.8×FY 2014: 3.8×FY 2015: 1.1×FY 2016: 5.5×FY 2017: 3.3×FY 2018: -9.4×FY 2019: 3.8×FY 2020: 3.7×
FY 2011 5y median 3.7× FY 2020
P/S 0.2×
FY 2011: 6.1×FY 2012: 6.4×FY 2013: 7.4×FY 2014: 2.0×FY 2015: 0.2×FY 2016: 0.2×FY 2017: 0.2×FY 2018: 0.3×FY 2019: 0.1×FY 2020: 0.2×
FY 2011 5y median 0.2× FY 2020
P/B 0.1×
FY 2011: 1.6×FY 2012: 1.5×FY 2013: 1.8×FY 2014: 0.4×FY 2015: 0.1×FY 2016: 0.3×FY 2017: 0.2×FY 2018: 0.3×FY 2019: 0.1×FY 2020: 0.1×
FY 2011 5y median 0.2× FY 2020
P/FCF -355×
FY 2011: -27.3×FY 2012: -150×FY 2013: 73.3×FY 2014: 9.2×FY 2015: -1.7×FY 2016: 19.6×FY 2017: -3.0×FY 2018: -37.4×FY 2019: -1.4×FY 2020: -355×
FY 2011 5y median -3.0× FY 2020
EV/EBITDA 3.0×
FY 2011: 7.9×FY 2012: 15.4×FY 2013: 13.8×FY 2014: 3.0×FY 2015: 1.7×FY 2016: 1.3×FY 2017: 4.6×FY 2018: 0.9×FY 2019: 10.0×FY 2020: 3.0×
FY 2011 5y median 3.0× FY 2020
EV/Sales 0.5×
FY 2011: 6.0×FY 2012: 6.3×FY 2013: 7.2×FY 2014: 1.9×FY 2015: 0.3×FY 2016: 0.3×FY 2017: 0.4×FY 2018: 0.5×FY 2019: 0.4×FY 2020: 0.5×
FY 2011 5y median 0.4× FY 2020
FCF Yield -0.3%
FY 2011: -3.7%FY 2012: -0.7%FY 2013: 1.4%FY 2014: 10.9%FY 2015: -59.2%FY 2016: 5.1%FY 2017: -33.8%FY 2018: -2.7%FY 2019: -70.3%FY 2020: -0.3%
FY 2011 5y median -2.7% FY 2020

Profitability

Gross Margin 12.9%
FY 2011: 81.1%FY 2012: 81.0%FY 2013: 67.6%FY 2014: 72.3%FY 2015: 23.8%FY 2016: 6.3%FY 2017: 12.5%FY 2018: 28.5%FY 2019: 2.8%FY 2020: 12.9%
FY 2011 5y median 12.5% FY 2020
Operating Margin 9.4%
FY 2011: 67.9%FY 2012: 32.8%FY 2013: 52.4%FY 2014: 55.5%FY 2015: 17.4%FY 2016: 4.1%FY 2017: 8.2%FY 2018: 1.9%FY 2019: -2.2%FY 2020: 9.4%
FY 2011 5y median 4.1% FY 2020
Net Margin 5.4%
FY 2011: 67.8%FY 2012: 32.8%FY 2013: 52.4%FY 2014: 55.4%FY 2015: 17.9%FY 2016: 3.9%FY 2017: 7.9%FY 2018: -3.5%FY 2019: 3.5%FY 2020: 5.4%
FY 2011 5y median 3.9% FY 2020
ROE 3.2%
FY 2011: 18.2%FY 2012: 7.9%FY 2013: 12.9%FY 2014: 12.3%FY 2015: 13.5%FY 2016: 5.2%FY 2017: 7.1%FY 2018: -3.2%FY 2019: 2.4%FY 2020: 3.2%
FY 2011 5y median 3.2% FY 2020
ROIC 4.4%
FY 2011: 18.2%FY 2012: 7.9%FY 2013: 12.9%FY 2014: 12.3%FY 2015: 12.0%FY 2016: 5.1%FY 2017: 6.4%FY 2018: -11.5%FY 2019: -1.2%FY 2020: 4.4%
FY 2011 5y median 4.4% FY 2020
ROA 2.5%
FY 2011: 16.2%FY 2012: 7.9%FY 2013: 11.0%FY 2014: 12.2%FY 2015: 12.1%FY 2016: 4.3%FY 2017: 6.1%FY 2018: -2.7%FY 2019: 1.8%FY 2020: 2.5%
FY 2011 5y median 2.5% FY 2020

Growth (YoY)

Revenue -2.1%
FY 2011: 0.0%FY 2012: 12.9%FY 2013: 10.6%FY 2014: 3.9%FY 2015: 282.8%FY 2016: 73.6%FY 2017: -21.0%FY 2018: -7.3%FY 2019: -25.8%FY 2020: -2.1%
FY 2011 FY 2020
Operating Income 514.6%
FY 2011: 0.0%FY 2012: -45.5%FY 2013: 76.8%FY 2014: 10.0%FY 2015: 19.9%FY 2016: -58.7%FY 2017: 56.7%FY 2018: -78.4%FY 2019: -186.2%FY 2020: 514.6%
FY 2011 FY 2020
EPS (diluted) 50.0%
FY 2011: 0.0%FY 2012: -37.5%FY 2013: 60.0%FY 2014: -12.5%FY 2015: 42.9%FY 2016: -60.0%FY 2017: 50.0%FY 2018: -142.3%FY 2019: 178.7%FY 2020: 50.0%
FY 2011 FY 2020
Free Cash Flow 99.4%
FY 2011: 0.0%FY 2012: 78.5%FY 2013: 360.9%FY 2014: 121.7%FY 2015: -305.8%FY 2016: 117.0%FY 2017: -688.0%FY 2018: 90.2%FY 2019: -718.3%FY 2020: 99.4%
FY 2011 FY 2020

Financial Health

Current Ratio 0.9×
FY 2011: 0.5×FY 2012: 9.6×FY 2013: 0.6×FY 2014: 22.9×FY 2015: 3.6×FY 2016: 4.5×FY 2017: 4.8×FY 2018: 1.8×FY 2019: 1.1×FY 2020: 0.9×
FY 2011 5y median 1.8× FY 2020
Quick Ratio 0.9×
FY 2011: 0.3×FY 2012: 5.7×FY 2013: 0.4×FY 2014: 12.6×FY 2015: 2.6×FY 2016: 3.1×FY 2017: 4.4×FY 2018: 0.9×FY 2019: 0.9×FY 2020: 0.9×
FY 2011 5y median 0.9× FY 2020
Debt / Equity 0.2×
FY 2011: 0.0×FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.1×FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.2×FY 2020: 0.2×
FY 2011 5y median 0.1× FY 2020
Net Debt / EBITDA 1.8×
FY 2011: -0.2×FY 2012: -0.1×FY 2013: -0.3×FY 2014: -0.1×FY 2015: 0.6×FY 2016: 0.2×FY 2017: 1.6×FY 2018: 0.3×FY 2019: 6.8×FY 2020: 1.8×
FY 2011 5y median 1.6× FY 2020
Interest Coverage 5.3×
FY 2011: 0.0×FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 15.1×FY 2017: 14.8×FY 2018: 2.4×FY 2019: -1.6×FY 2020: 5.3×
FY 2011 5y median 5.3× FY 2020

Dividends

Dividend Yield 0.0%
FY 2011: 0.0%FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2011 5y median 0.0% FY 2020
Payout Ratio 0.0%
FY 2011: 0.0%FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2011 5y median 0.0% FY 2020

Annual · latest fiscal year ends 2020-12-31